ArtiSential versus conventional laparoscopic colorectal cancer surgery: a multicenter retrospective matched cohort study Authors: Dae Hee Pyo, Yoon Suk Lee, Byung Soh Min, Jaeim Lee, Chang Hyun Kim, Heung-Kwon Oh, Yong Sik Yoon, Donghwan Bae, Jung Wook Huh Published: 2024 ABSTRACT Background:This study aims to compare outcomes of colorectal cancer surgeries performed using the newly developed articulating laparoscopic instrument, ArtiSential, with those using conventional non-articulating or rigid laparoscopic instruments.Methods:This multicenter, retrospective, matched cohort study enrolled patients with colorectal cancer undergoing laparoscopic surgery in seven tertiary referral hospitals from January 2021 to October 2022. A 1:1 propensity score matching was performed between the articulating (Arti-LAP) and conventional (Rigid-LAP) laparoscopic groups. The primary outcome was the overall incidence of short-term complications.Results:The study initially comprised 694 and 2008 patients in the Arti-LAP and Rigid-LAP groups, respectively. After matching, each group consisted of 694 patients, with no significant differences in baseline clinical characteristics. The mean operation time was 161±32 min in Arti-LAP and 152±25 min in Rigid-LAP groups (P=0.105). Open conversion rates were 0% (0/694) in Arti-LAP and 1.0% (7/694) in Rigid-LAP groups (P=0.024). Overall morbidity rates were 9.5% (66/694) in Arti-LAP and 12.8% (89/694) in Rigid-LAP (P=0.061), with similar rates of severe morbidities. Specimen quality was acceptable in both groups. Multivariable regression analysis showed that the choice of instrument type (articulating or rigid) was not associated with perioperative morbidity. Despite a short median follow-up period of 19.5 months, no significant difference in disease-free survival was observed between the groups.Conclusion:Laparoscopic surgery using ArtiSential was performed safely and effectively for patients with colorectal cancer. Articulating laparoscopic instruments may offer an advantage in reducing open conversion rates. Introduction Highlights Morbidity in colorectal surgery between articulating and conventional laparoscopic instruments is comparable. Morbidity in colorectal surgery between articulating and conventional laparoscopic instruments is comparable. Articulating laparoscopic instruments are associated with a significantly decreased conversion rate, while they offer more convenience in the deep, narrow pelvis and handling of large tumors, in comparison to conventional laparoscopic instruments. Articulating laparoscopic instruments are associated with a significantly decreased conversion rate, while they offer more convenience in the deep, narrow pelvis and handling of large tumors, in comparison to conventional laparoscopic instruments. Articulating laparoscopic instruments are the precursors of robotic surgery, and despite the demanding learning curve, they can be effectively implemented in the operating room. Articulating laparoscopic instruments are the precursors of robotic surgery, and despite the demanding learning curve, they can be effectively implemented in the operating room. Minimally invasive surgery is increasingly recognized as a safe and feasible approach for colorectal cancer treatment, offering significant benefits over traditional methods1,2. However, the complexity of laparoscopic colorectal procedures, notably total mesorectal excision or lateral pelvic lymph node dissection in the deep and narrow pelvis, and D3 lymph node dissection near central vessels, demands extensive training to achieve proficiency3–5. These techniques pose greater challenges compared with open surgeries, largely due to limited instrument mobility and the fulcrum effect inherent in laparoscopic tools. Conventional laparoscopic instruments, characteristically rigid and straight, often impede surgical maneuverability, restricting access to targeted areas. In response, robotic surgical systems, with their flexible wristed arms, have substantially mitigated these limitations, enhancing movement range and reducing surgeon fatigue6. Nonetheless, high costs and specific operating room requirements limit their widespread adoption7. Recent advancements in laparoscopic technology have led to the introduction of articulating, hand-held flexible instruments like ArtiSential. These tools offer enhanced dexterity, enabling easier navigation within challenging anatomical regions compared with traditional laparoscopic instruments8–10. With their ability to replicate the movements of a robotic arm, these devices potentially offer greater surgical precision, especially in confined spaces, which may improve short-term surgical outcomes. However, the clinical effectiveness and non-inferiority of ArtiSential compared with conventional laparoscopic surgery require more thorough validation. Current evidence, largely from small-scale studies or single-center experiences, is insufficient. Therefore, this study was designed to evaluate the safety and clinical feasibility of laparoscopic surgery utilizing the articulating laparoscopic device in comparison to surgeries performed with conventional non-articulating or rigid laparoscopic devices. Methods Patients This study was reported in line with the STROCSS guideline11. This study was designed as a multicenter, retrospective, matched cohort study. Patients with colorectal cancer undergoing laparoscopic surgery in seven tertiary referral hospitals from January 2021 to October 2022 were evaluated. All participants had histologically confirmed adenocarcinomas located in the colon or rectum. Exclusion criteria comprised emergent surgeries, previous open laparotomies for any reason, familial or hereditary cancers, stage IV disease, and neoadjuvant chemoradiotherapy or chemotherapy. The Institutional Review Boards of the participating institutions approved a waiver of informed consent, as this study was retrospective and utilized only anonymized Electronic Medical Record (EMR) data, posing no risk to the patients involved. The ArtiSential Colorectal Surgery Database was created by extracting the following data from each center’s electronic medical records: (1) demographic and baseline clinical details, (2) pathological outcomes, (3) intraoperative details, (4) postoperative recovery outcomes, (5) any perioperative complications, and (6) last day of follow-up with disease status. The primary outcome was the overall incidence of perioperative morbidity. Secondary outcomes included severe morbidity (defined as complications exceeding a Clavien–Dindo classification of IIIb), unexpected intraoperative events, length of hospital stay, mortality rates, and disease-free survival. ArtiSential ArtiSential is the first multi-jointed, articulating laparoscopic instrument, offering a full range of motion through its end effector, which is fully and precisely synchronized with the surgeon’s hand movements. Due to its flexible design, it provides enhanced access to various anatomical structures. The ArtiSential line includes a variety of instruments such as monopolar energy devices, bipolar dissectors, needle drivers, and forceps. Typically, hook-type and spatula-type devices were used in the surgeon’s right hands, while bipolar grasper-type devices were used in their left hands. The choice between hook and spatula devices was based on the surgeons’ preferences. Statistics A propensity score was generated using logistic regression, incorporating covariates such as age, sex, body mass index (BMI), tumor location, and type of surgery. The variables for propensity score matching were selected by the researchers based on clinically important baseline characteristics. Patients were then matched in a 1:1 ratio based on these scores. In the matched cohort, univariate and multivariate analyses were conducted to assess whether the choice of laparoscopic instrument type was associated with perioperative morbidity. Categorical variables were analyzed using Pearson’s chi-square test or Fisher’s exact test, while quantitative data were evaluated using Student’s t test. The Kaplan–Meier curve and Cox proportional hazards regression analysis were employed to compare disease-free survival between the groups. Disease-free survival was defined as the time from the date of surgery to the last follow-up for patients without recurrence and from the date of surgery to the date of radiological diagnosis of recurrence. A P value of less than 0.05 was considered statistically significant. All statistical analyses were performed using R software, version 4.01. Results Patient characteristics We enrolled 694 patients in the Arti-LAP group and 2008 in the Rigid-LAP group (Table 1). The median ages were 65 and 63 years, respectively (P=0.091), with 59.1% male in the Arti-LAP group and 55.6% in the Rigid-LAP group (P=0.125). Before matching, significant differences were observed in comorbidities, tumor locations, and surgical procedures. Propensity score matching was used to adjust for these disparities. After matching, no significant clinicopathologic differences were found between the groups. Table 1Patient characteristics before and after matching.Before matchingAfter matchingArti-LAP (N=694)Rigid-LAP (N=2008) P Rigid-LAP (N=694) P Age, median (IQR)65 (58–74)63 (54–71)0.09165 (59–73)0.531Sex, n (%)0.1250.622 Male410 (59.1)1117 (55.6)420 (60.5) Female284 (40.9)891 (44.4)274 (39.5)BMI, mean (SD), kg/m2 23.7 (3.6)23.9 (3.5)23.8 (3.5)Comorbidity, n (%)< 0.0010.975 DM82 (11.8)198 (9.9)79 (11.4) Hypertension177 (25.5)490 (24.4)174 (25.1) Others82 (11.8)301 (15.0)83 (12.0)Preoperative CEA, median (IQR), ng/ml2.5 (1.4–4.5)2.6 (1.6–4.5)0.2362.5 (1.6–4.5)0.312Location of tumor, n (%)<0.0010.999 Ascending colon173 (24.9)529 (26.3)173 (24.9) Transverse colon33 (4.8)96 (4.8)33 (4.8) Descending colon64 (9.2)95 (4.7)60 (8.6) Sigmoid colon174 (25.1)561 (27.9)176 (25.4) Rectosigmoid junction86 (12.4)227 (11.4)84 (12.1) Rectum164 (23.6)500 (24.9)168 (24.2)Name of operation, n (%)<0.0010.969 Right hemicolectomy197 (28.3)582 (29.0)199 (28.7) Transverse colectomy12 (1.7)11 (0.5)10 (1.4) Left hemicolectomy29 (4.1)124 (6.2)30 (4.3) Anterior resection211 (30.1)596 (29.7)211 (30.4) Low anterior resection208 (29.8)627 (31.3)208 (29.8) Intersphincteric resection24 (3.5)52 (2.6)25 (3.6) Hartmann’s operation3 (0.4)7 (0.3)3 (0.4) Abdominoperineal resection15 (2.1)9 (0.4)8 (1.2)BMI, body mass index; CEA, carcinoembryonic antigen; DM, diabetes mellitus; IQR, interquartile range; SD, standard deviation. Patient characteristics before and after matching. BMI, body mass index; CEA, carcinoembryonic antigen; DM, diabetes mellitus; IQR, interquartile range; SD, standard deviation. Histological characteristics The pathological outcomes were compared between the groups (Table 2). There were slight variations in the distribution of cell differentiation types. Specifically, the Arti-LAP group had a higher proportion of well-differentiated and moderately differentiated adenocarcinomas, while the Rigid-LAP group had a slightly higher proportion of poorly differentiated adenocarcinomas and mucinous/signet ring cell carcinomas. The distribution of pT stage and pN stage was similar between the groups. However, a significant difference was noted in the rate of perineural invasion (P=0.003). Table 2Histological characteristics.Arti-LAP (N=694)Rigid-LAP (N=694) P Cell differentiation, n (%)0.162 Adenocarcinoma, well182 (26.2)149 (21.4) Adenocarcinoma, moderate486 (70.1)459 (66.1) Adenocarcinoma, poorly17 (2.4)70 (10.1) Mucinous/SRC9 (1.3)16 (2.4)pT stage, n (%)0.320 Tis or T1190 (27.4)182 (26.2) T2149 (21.4)161 (23.2) T3313 (45.1)294 (42.3) T442 (6.1)57 (8.3)pN stage, n (%)0.237 N0432 (62.2)438 (63.1) N1203 (29.3)182 (26.2) N259 (8.5)74 (10.7)TNM stage, n (%)0.745 0 or I279 (40.2)273 (39.3) II153 (22.0)165 (23.8) III262 (37.8)256 (36.9)Number of total LNs17 (10–25)16 (11–23)0.316Lymphovascular invasion, n (%)139 (20.1)120 (17.3)0.191Perineural invasion, n (%)135 (19.5)182 (26.2)0.003Proximal margin, cm (IQR)8.5 (6.5–13.0)9.0 (7.5–13.5)0.726Distal margin, cm (IQR)7.9 (5.4–14.3)9.0 (6.5–16.3)0.423CRM, circumferential margin; IQR, interquartile range; LN, lymph node; SRC, singet ring cell carcinoma; TME, total mesorectal excision. Histological characteristics. CRM, circumferential margin; IQR, interquartile range; LN, lymph node; SRC, singet ring cell carcinoma; TME, total mesorectal excision. Intraoperative and early postoperative outcomes In the matched cohort, short-term outcomes were compared between the groups (Table 3). The overall morbidity rate was lower in the Arti-LAP group (9.5%) compared with the Rigid-LAP group (12.8%), although this difference did not reach statistical significance (P=0.061). Severe complication rates were comparable, with 2.0% in the Arti-LAP group and 1.9% in the Rigid-LAP group, showing no significant difference (P=1.000). There were no mortalities in either group. The median operation time was shorter in the Rigid-LAP group, with a median of 152 min compared with 161 min in the Arti-LAP group, but this difference was not statistically significant (P=0.105). Estimated blood loss was similar between the groups. Notably, the rate of open conversion was different, with no cases in the Arti-LAP group and seven cases (1.0%) in the Rigid-LAP group (P=0.024). The reasons for conversion included difficulties in manipulating lesions due to tumor size in six cases (five low anterior resections and one right hemicolectomy) and uncontrolled bleeding in one case of right hemicolectomy. The length of hospital stay was similar between the groups, with both showing a median stay of 7 days. Table 3Intraoperative and early postoperative outcomes.Arti-LAP (N=694)Rigid-LAP (N=694) P EBL, mean (SD), ml50 (20–400)30 (10–500)0.291Operation time, median (SD), min161 (32)152 (25)0.105Open conversion, n (%)07 (1.0)0.024Intraoperative transfusion, n (%)11 (1.6)9 (1.3)0.532Hospital stays, median (IQR), day7 (4–14)7 (5–13)0.392First sips of water, median (IQR), day1 (1–3)1 (1–3)0.639First soft blended diet, median (IQR), day2 (1–4)2 (1–3)0.792First bowel movement, median (IQR), day2 (1–4)2 (1–4)0.921Morbidity, n (%)66 (9.5)89 (12.8)0.061Ileus19 (2.7)21 (3.0)0.873Anastomotic leakage14 (2.0)13 (1.9)1.000Anastomotic bleeding5 (0.7)1 (0.1)0.220Intra-abdominal bleeding1 (0.1)0–Surgical site infection15 (2.2)25 (3.6)0.149 Superficial/deep6 (0.6)15 (2.2)0.079 Organ9 (1.3)10 (1.4)1.000Urinary retention12 (1.7)14 (2.0)0.843 Morbidity CD ≥IIIb, n (%)14 (2.0)13 (1.9)1.000 Mortality, n (%)00–CD, Clavien–Dindo classification; EBL, estimated blood loss; IQR, interquartile range; SD, standard deviation. Intraoperative and early postoperative outcomes. CD, Clavien–Dindo classification; EBL, estimated blood loss; IQR, interquartile range; SD, standard deviation. ArtiSential utilization In the Arti-LAP group, bilateral use of ArtiSential instruments occurred in 430 patients (62.0%) (Table 4). Notably, there was a distinct difference in the primary type of ArtiSential instrument used in the right hand between right hemicolectomy (RHC) and anterior resection/low anterior resection (AR/LAR) procedures. The Monopolar Hook was predominantly used in RHC (72.6%), whereas the Monopolar Spatula was favored in AR/LAR (69.4%). Table 4ArtiSential utilization. N=694Utilization pattern, n (%) Bilateral ArtiSential use430 (62.0) Unilateral ArtiSential use (right hand)208 (22.9) Unilateral ArtiSential use (left hand)56 (8.1)Right-hand ArtiSential utilization, n (%) Monopolar Spatula396 (62.1) Monopolar Hook242 (37.9)Left-hand ArtiSential utilization, n (%) Fenestrated Forceps486 (100)Right-hand ArtiSential utilization during RHC Monopolar Hook463 (72.6) Monopolar Spatula175 (27.4)Right-hand ArtiSential utilization during AR/LAR Monopolar Hook195 (30.6) Monopolar Spatula443 (69.4)AR, anterior resection; LAR, low anterior resection; RHC, right hemicolectomy. ArtiSential utilization. AR, anterior resection; LAR, low anterior resection; RHC, right hemicolectomy. Correlation and regression analysis Univariate analysis identified a body mass index over 24 kg/m2, rectosigmoid junction or rectal cancer, operation times exceeding 160 min, and intraoperative transfusions as factors significantly associated with overall morbidity (Table 5). Multivariate analysis revealed that rectosigmoid junction or rectal cancer and intraoperative transfusions were significant risk factors for overall complications within 1 month after surgery. The choice of instrument type, whether articulating or rigid, was not associated with perioperative morbidity. Table 5Univariable and multivariable regression analysis for the overall incidence of 30-day complications.Univariate regressionMultivariate regressionHazard ratioCI P Hazard ratioCI P Age ≥651.120.87–1.560.523Male2.320.92–3.210.234BMI ≥24 kg/m2 1.511.05–2.190.047Preop CEA1.020.53–1.320.420Tumor location Colon1 (reference) RSJ or rectum1.931.25–2.300.0031.241.14–1.920.032pT stage Tis or T11 (reference) T21.020.68–1.140.621 T31.320.63–2.120.527 T41.650.95–4.320.392pN stage N01 (reference) N12.120.55–2.470.712 N21.530.89–1.960.553EBL >50 ml0.930.82–1.150.215Operation time >160 min3.241.15–4.010.0392.930.94–3.120.095Intraoperative transfusion4.222.29–5.15<0.0013.051.90–4.72<0.001Laparoscopic instrument Rigid-LAP1 (reference) Arti-LAP0.890.75–1.310.462BMI, body mass index; CEA, carcinoembryonic antigen; CI, confidence interval; EBL, estimated blood loss; RSJ, rectosigmoid junction. Univariable and multivariable regression analysis for the overall incidence of 30-day complications. BMI, body mass index; CEA, carcinoembryonic antigen; CI, confidence interval; EBL, estimated blood loss; RSJ, rectosigmoid junction. Survival analysis The median follow-up period for all patients was 19.5 months, with 19.2 months in the Arti-LAP group and 20.1 months in the Rigid-LAP group. There was no significant difference in disease-free survival between the two groups during the follow-up period (P=0.39) (Fig. 1). At 18 months, the disease-free survival rate was 93.0% in the Arti-LAP group and 92.4% in the Rigid-LAP group. Kaplan-Meier Survival Curves Comparing Disease-Free Survival Between Arti-LAP and Rigid-LAP Groups. Discussion To the best of our knowledge, this is the first multicenter study and the largest cohort worldwide to evaluate the safety and efficacy of articulating laparoscopic surgery in colorectal cancer. Notably, there were no instances of conversion to open surgery in the Arti-LAP group. The overall morbidity rates were 9.5% in the Arti-LAP group and 12.8% in the Rigid-LAP group (P=0.061), with no mortalities reported across all patients. Furthermore, despite the inherently limited follow-up period due to ArtiSential’s recent introduction as a cutting-edge instrument, our comparison of disease-free survival rates demonstrated that surgeries using ArtiSential were not inferior in terms of short-term oncologic outcomes, providing valuable initial evidence of its efficacy in cancer surgery. Laparoscopic surgery has seen a surge in popularity since its debut in the late 1980’s for cholecystectomy12. With advancements in laparoscopic instruments, the range of applicable surgeries has broadened considerably. Given that the colorectum extends across the whole abdominal cavity, laparoscopic colorectal cancer surgery poses significant challenges, demanding dynamic manipulation across multiple regions. The learning curve is notably steeper for advanced cancer surgeries that necessitate intricate techniques to minimize damage to central vessels and surrounding organs while ensuring thorough lymph node dissection13,14. A key challenge in laparoscopic surgery is the straight design of conventional instruments, which makes precise targeting difficult. In confined areas like the pelvis, limited mobility can cause instrument collisions with the camera or other tools, hindering accurate dissection. Surgical robots, with articulated arms mimicking human wrist movements, have emerged to overcome the limitations of traditional laparoscopic instruments. However, their high cost and the need for specialized robotic systems may limit accessibility, especially for patients with financial constraints. As a result, there is a growing demand for innovative laparoscopic tools that can integrate with existing systems without the high costs of robotic surgery. ArtiSential, a cutting-edge articulating laparoscopic instrument, provides 360-degree movement similar to that of a robotic arm8,9,15,16. This fully mechanical device, requiring no electrical power, can be effortlessly used with a standard laparoscopic trocar. Equipped with a variety of tips, including hooks, spatulas, bipolar graspers, and needle drivers, ArtiSential is especially beneficial for procedures such as right hemicolectomy and low anterior resection. During standard laparoscopic right hemicolectomies, the camera and instruments are typically aligned linearly, which is crucial while navigating lymph nodes around the superior mesenteric artery (SMA) and superior mesenteric vein (SMV)14. This alignment, however, restricts the field of view, representing a critical and hazardous phase in right hemicolectomies. ArtiSential offers a solution; its articulating tip permits precise angular access, even when not aligned with the camera. Additionally, in hepatic flexure colon mobilization, especially with bulky tumors, ArtiSential’s flexible joints can be angled downward, enhancing surgical site access. The wide jaw of the ArtiSential grasper also provides stable counter-traction over a broad area of the right mesocolon. The ArtiSential’s articulation is particularly beneficial in low anterior resection surgeries, especially for patients with a narrow, deep pelvis, such as obese individuals and males17. The articulation of ArtiSential proves beneficial when mobilizing the descending colon on the left lateral side or addressing the splenic flexure in patients with tortuous or sharply angled aortas. Moreover, in cases where the sacral promontory is anteriorly protruded, creating a steeply angled pelvic reflex, conventional straight laparoscopic tools face difficulty with optimal access – a challenge effectively managed by ArtiSential. The safety, efficacy, and several advantages of laparoscopic surgery using this instrument have been demonstrated in early small-scale studies involving gynecological surgeries and gastric cancer operations18,19. Similar to our findings, these studies emphasize a key benefit of articulating instruments: their ability to effectively and thoroughly dissect curved and tortuous anatomical spaces in obese patients, which were previously difficult to fully access with conventional rigid instruments. Nonetheless, ArtiSential instruments present certain challenges in terms of a learning curve. The pistol grip design, which differs from the conventional scissor grip, along with the instrument’s heavier weight and larger handpiece, requires a period of adjustment. Since all ArtiSential procedures in this study were performed by experienced laparoscopic colorectal surgeons, further research is needed to quantify the learning curve for less experienced surgeons. Limitations This study has several limitations. First, its retrospective design may impact the results, although this was addressed by including consecutive patients from multiple centers and applying propensity score matching to balance clinicopathological differences. Second, the data for the ArtiSential group was collected from various centers, whereas the conventional group data came from a single center, potentially introducing selection bias. To address this, we included all consecutive patients treated during the study period at each institution, applied uniform selection criteria across centers, and conducted propensity score matching analysis. While these steps significantly minimize potential bias, we acknowledge that having multicenter data for both groups would have provided a more robust comparison. Third, as all surgeries were performed by experienced laparoscopic colorectal surgeons, the findings may not reflect outcomes achievable by less experienced surgeons. Fourth, the study lacks detailed data on the specific percentage of ArtiSential instrument usage within each procedure. Lastly, the relatively short follow-up period limits our ability to draw definitive conclusions about long-term oncologic outcomes, even though we compared disease-free survival rates. This limitation is inherent in studies involving recently developed medical devices, where long-term follow-up data is naturally scarce. We expect that future studies with extended follow-up periods will address this limitation and provide more comprehensive insights into the long-term oncologic outcomes of surgeries using these innovative instruments. This multicenter comparative analysis evaluates the efficacy and safety of ArtiSential in colorectal cancer surgeries. Our findings suggest that laparoscopic procedures using ArtiSential are both safe and effective when performed by experienced laparoscopic surgeons, though the study’s retrospective design introduces potential selection bias. While we did not observe significant differences in oncologic outcomes between the two approaches, the potential long-term benefits of articulated instruments in narrow anatomical spaces should not be overlooked. The enhanced dexterity and precision offered by these tools could lead to better lymph node harvesting and more meticulous dissection. However, further long-term studies are needed to determine if these advantages translate into improved outcomes, such as reduced recurrence and increased survival rates. We are currently advancing the STARC trial (ClinicalTrials.gov ID: NCT05566249), a prospective study designed to compare the efficacy and long-term outcomes of ArtiSential and robotic methods in rectal cancer surgeries. We expect the results to provide valuable insights. In conclusion, laparoscopic surgery using ArtiSential was performed safely and effectively in colorectal cancer patients. Articulating instruments may offer a distinct advantage in preventing open conversions. Ethical approval This study followed the CONSORT 2010 statement and was performed in accordance with the Declaration of Helsinki. The protocol of this study was approved by the Institutional Review Board of Samsung Medical Center, the principal research institution. (IRB number : SMC-2022-01-174). Consent The Institutional Review Board of the participating institutions approved a waiver of informed consent because this study was retrospective and utilized only anonymized EMR data, posing no risk to the patients involved. Source of funding This work was supported by the Korea Medical Device Development Fund grant funded by the Korean government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: RS-2022-00141193). Author contribution D.H.P.: formal analysis, investigation, data curation, writing – original draft, and writing – review and editing; Y.S.L.: conceptualization, methodology, investigation, resources, and supervision; B.S.M., J.L., C.H.K., H.K.O., and Y.S.Y.: investigation and resources; D.B.: resources and funding acquisition; J.W.H.: conceptualization, methodology, validation, investigation, resources, writing – review and editing, supervision, project administration, and funding acquisition. Conflicts of interest disclosure The authors declare no conflicts of interest. Research registration unique identifying number (UIN) This study was registered with Clinicaltrials.gov (ID : NCT05566249). Guarantor Jung Wook Huh. Data availability statement The data that support the findings of this study are available from the corresponding author, Jung Wook Huh, upon reasonable request. Provenance and peer review Not commissioned, externally peer-reviewed.